SB Financial Group (NASDAQ:SBFG) Lowered to Hold at Zacks Investment Research

Share on StockTwits

Zacks Investment Research cut shares of SB Financial Group (NASDAQ:SBFG) from a strong-buy rating to a hold rating in a research note published on Tuesday, Zacks.com reports.

According to Zacks, “SB Financial Group, Inc. is a financial services holding company with two wholly-owned operating subsidiaries: State Bank and RDSI Banking Systems. State Bank offers a full range of financial services for consumers and small businesses, including wealth management, mortgage banking, commercial and agricultural lending. RDSI provides item processing services to community banks located in the Midwest. SB Financial Group, Inc., formerly known as Rurban Financial Corp., is based in Defiance, Ohio. “

Separately, ValuEngine cut SB Financial Group from a hold rating to a sell rating in a report on Thursday, April 2nd.

NASDAQ:SBFG opened at $16.73 on Tuesday. SB Financial Group has a 12-month low of $9.02 and a 12-month high of $20.49. The firm has a market cap of $125.10 million, a price-to-earnings ratio of 12.67 and a beta of 1.38. The company’s 50-day moving average is $15.96 and its two-hundred day moving average is $16.66. The company has a current ratio of 0.99, a quick ratio of 0.98 and a debt-to-equity ratio of 0.12.

SB Financial Group (NASDAQ:SBFG) last posted its quarterly earnings data on Thursday, April 23rd. The financial services provider reported $0.09 earnings per share for the quarter, missing analysts’ consensus estimates of $0.24 by ($0.15). SB Financial Group had a net margin of 16.90% and a return on equity of 9.73%. The firm had revenue of $10.71 million during the quarter, compared to analyst estimates of $12.89 million. On average, equities research analysts forecast that SB Financial Group will post 1.58 earnings per share for the current fiscal year.

A number of hedge funds have recently modified their holdings of SBFG. UBS Group AG raised its stake in SB Financial Group by 310.2% during the fourth quarter. UBS Group AG now owns 1,817 shares of the financial services provider’s stock worth $36,000 after purchasing an additional 1,374 shares during the period. Northwestern Mutual Wealth Management Co. increased its holdings in shares of SB Financial Group by 118.9% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 5,472 shares of the financial services provider’s stock worth $108,000 after buying an additional 2,972 shares during the last quarter. Southside Capital LLC purchased a new position in shares of SB Financial Group in the 4th quarter worth $126,000. Renaissance Technologies LLC boosted its holdings in SB Financial Group by 9.9% in the fourth quarter. Renaissance Technologies LLC now owns 13,300 shares of the financial services provider’s stock valued at $262,000 after acquiring an additional 1,200 shares during the last quarter. Finally, Morgan Stanley grew its position in SB Financial Group by 101.3% during the first quarter. Morgan Stanley now owns 15,845 shares of the financial services provider’s stock valued at $176,000 after acquiring an additional 7,973 shares during the period. 46.67% of the stock is owned by hedge funds and other institutional investors.

About SB Financial Group

SB Financial Group, Inc, through its subsidiaries, provides range of banking and wealth management services to individual and corporate customers primarily in northwest Ohio and northeast Indiana. It accepts deposits, such as checking accounts, savings accounts, money market accounts, demand deposits, and time certificates of deposit.

See Also: Return on Investment (ROI) Defined, Explained

Get a free copy of the Zacks research report on SB Financial Group (SBFG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for SB Financial Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SB Financial Group and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Pacira Biosciences  Price Target Raised to $54.00
Pacira Biosciences Price Target Raised to $54.00
Oxford Square Capital  Upgraded to “Hold” by Zacks Investment Research
Oxford Square Capital Upgraded to “Hold” by Zacks Investment Research
Old Second Bancorp  Upgraded to Buy at Zacks Investment Research
Old Second Bancorp Upgraded to Buy at Zacks Investment Research
Osmotica Pharmaceuticals  Downgraded to Hold at Zacks Investment Research
Osmotica Pharmaceuticals Downgraded to Hold at Zacks Investment Research
$0.07 EPS Expected for PDC Energy Inc  This Quarter
$0.07 EPS Expected for PDC Energy Inc This Quarter
$0.21 EPS Expected for Wheaton Precious Metals Corp  This Quarter
$0.21 EPS Expected for Wheaton Precious Metals Corp This Quarter


 
© 2006-2020 Zolmax.